Title : Vascular risk: Prediction is the mother of prevention
Abstract:
In vascular medicine, the greatest challenge is not the complexity of the disease, but the silence with which it evolves. We must now harness predictive intelligence to break that silence.
This presentation posits that the potential of vascular medicine lies in the seamless integration of comprehensive clinical phenotyping with advanced molecular diagnostics. By synthesizing metabolic, environmental, and behavioral data—such as dietary patterns, stress, sleep architecture, and systemic biomarkers—we can establish a more precise, population-specific risk profile. Moving beyond traditional scores, we must embrace a holistic understanding of the cardiovascular system that accounts for the complex interplay between systemic health and individual susceptibility.
Precision in prevention requires an integrated understanding of the human body’s molecular language. Recent insights into the molecular language of stroke reveal that systemic blood-based biomarkers can effectively serve as surrogates for central pathology. Through the identification of conserved transcriptomic signatures related to oxidative stress, neuroinflammation, and vascular remodeling, we are uncovering the potential to monitor vascular health in real-time through minimally invasive means. This molecular lens provides a framework for detecting subclinical disease progression long before symptoms arise, offering a window for timely, personalized intervention.
The mandate for the next generation of vascular medicine is clear: we must replace the paradigmatic inertia of "wait and see" with the precision of "detect and defend”. By anchoring our strategies in biological rigor and predictive foresight, we can intervene in the cascade of disease while the system retains its plasticity. Ultimately, in the realm of vascular health, the most significant intervention is not the one that saves a life in crisis, but the one that ensures the crisis never occurs.
